A clinical state where target cells, such as those in muscle, fat, and liver tissue, exhibit a reduced or impaired response to the action of insulin, the pancreatic hormone responsible for glucose uptake. This condition is a central feature of metabolic dysfunction, leading to compensatory hyperinsulinemia and eventually elevated blood glucose levels. It represents a critical disruption in the body’s energy regulation system.
Origin
The term is a compound of the hormone ‘insulin’ and ‘insensitivity,’ clearly describing a diminished biological response to the signaling molecule. It is foundational to the endocrinology and pathology of type 2 diabetes, metabolic syndrome, and other chronic diseases.
Mechanism
Insulin insensitivity occurs at the cellular level, often due to chronic overexposure to glucose and free fatty acids, leading to defects in the insulin receptor signaling cascade. Specifically, the phosphorylation of key signaling proteins, such as IRS-1, is impaired, preventing the translocation of GLUT4 glucose transporters to the cell membrane. The pancreas attempts to overcome this resistance by increasing insulin secretion, perpetuating a state of hormonal imbalance.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.